Pediatrix Medical Group MD Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Pediatrix Medical Group in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pediatrix Medical Group's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pediatrix Medical Group's cash provided by (used in) financing activity, including discontinued operation?
- Pediatrix Medical Group (MD) reported cash provided by (used in) financing activity, including discontinued operation of -$27.64M in Q1 2026.
- How has Pediatrix Medical Group's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Pediatrix Medical Group's cash provided by (used in) financing activity, including discontinued operation decreased by 357.9% year-over-year, from -$6.04M to -$27.64M.
- What is the long-term trend for Pediatrix Medical Group's cash provided by (used in) financing activity, including discontinued operation?
- Over 3 years (2022 to 2025), Pediatrix Medical Group's cash provided by (used in) financing activity, including discontinued operation has grown at a -39.6% compound annual growth rate (CAGR), from -$487.55M to -$107.49M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.